Negative regulators of Wnt signaling pathway SFRP1 and SFRP3 expression in preterm and term pathologic placentas

J Matern Fetal Neonatal Med. 2018 Nov;31(22):2971-2979. doi: 10.1080/14767058.2017.1359830. Epub 2017 Aug 7.

Abstract

Objective: Since Wnt signaling pathway plays a pivotal role in the placental development, we explored the expression of its negative regulators, SFRP1 and SFRP3 proteins in placentas from pathological pregnancies and compared their levels with those in healthy placentas.

Methods: Placentas (n = 79) were stained for SFRP1, and SFRP3 proteins by immunohistochemistry and their expression levels were quantified by stereological variable of volume density (Vv, mm°).

Results: Significantly higher expressions of SFRP1 and SFRP3 were found in all investigated groups of term and preterm pathologic placentas as well as in preterm control placentas in comparison with normal-term placentas.

Conclusions: Our findings indicate the active involvement of negative Wnt regulators SFRP1/SFRP3 in placental development and important role in pathology of pregnancy.

Keywords: High maternal blood pressure; Wnt signaling pathway; immunohistochemistry; intrauterine growth restriction (IUGR); placenta; secreted frizzled-related proteins (SFRP).

MeSH terms

  • Adult
  • Case-Control Studies
  • Female
  • Humans
  • Intercellular Signaling Peptides and Proteins / metabolism*
  • Intracellular Signaling Peptides and Proteins / metabolism*
  • Membrane Proteins / metabolism*
  • Placenta / metabolism*
  • Pregnancy
  • Pregnancy Complications / metabolism*
  • Wnt Signaling Pathway*

Substances

  • Intercellular Signaling Peptides and Proteins
  • Intracellular Signaling Peptides and Proteins
  • Membrane Proteins
  • SFRP1 protein, human
  • WD repeat containing planar cell polarity effector